partnerships

OSE to lead mRNA project with €1.3M from French government

OSE Immunotherapeutics is leading an initiative aimed at creating new mRNA therapeutics with a 1.3 million euro investment from the French government.

Gabrielle Masson May 21, 2025 4:26pm

Revised Blueprint-VantAI deal turns focus to molecular glues

May 20, 2025 10:32am

Tempest, amid cash drought, hunts for liver cancer drug partner

Apr 10, 2025 7:24am

AI drug discovery pill machine learning drug targets data

Charles River and Valo pact nets preclinical lupus asset

Mar 26, 2025 6:30am

Opko, Entera share cost of 1st oral GLP-1/glucagon agonist study

Mar 17, 2025 10:10am

Graphic of a fork in the road with arrows pointing in either direction

BMS' MyoKardia scraps heart muscle pact with Fulcrum

Mar 5, 2025 5:30am